Recombinant multi-species USP19 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine USP19 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Protein ubiquitination controls many intracellular processes, including cell cycle progression, transcriptional activation, and signal transduction. This dynamic process, involving ubiquitin conjugating enzymes and deubiquitinating enzymes, adds and removes ubiquitin. Deubiquitinating enzymes are cysteine proteases that specifically cleave ubiquitin from ubiquitin-conjugated protein substrates. This protein is a ubiquitin protein ligase and plays a role in muscle wasting. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2017]
The Alternative Names of target: 8430421I07Rik,Deubiquitinating enzyme 19,USP19,Ubiquitin carboxyl-terminal hydrolase 19,Ubiquitin thioesterase 19,Ubiquitin-specific-processing protease 19,Usp19,ZMYND9,Zinc finger MYND domain-containing protein 9,Zmynd9

Target products collectionGo to USP19 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP2255-Ag-1/ GM-Tg-hg-IP2255-Ag-2 Human USP19 protein Human
GM-Tg-rg-IP2255-Ag-1/ GM-Tg-rg-IP2255-Ag-2 Rat USP19 protein Rat
GM-Tg-mg-IP2255-Ag-1/ GM-Tg-mg-IP2255-Ag-2 Mouse USP19 protein Mouse
GM-Tg-cynog-IP2255-Ag-1/ GM-Tg-cynog-IP2255-Ag-2 Cynomolgus/Rhesus macaque USP19 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP2255-Ag-1/ GM-Tg-felg-IP2255-Ag-2 Feline USP19 protein Feline
GM-Tg-cang-IP2255-Ag-1/ GM-Tg-cang-IP2255-Ag-2 Canine USP19 protein Canine
GM-Tg-bovg-IP2255-Ag-1/ GM-Tg-bovg-IP2255-Ag-2 Bovine USP19 protein Bovine
GM-Tg-equg-IP2255-Ag-1/ GM-Tg-equg-IP2255-Ag-2 Equine USP19 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP2255-Ag-1/ GM-Tg-hg-IP2255-Ag-2; GM-Tg-rg-IP2255-Ag-1/ GM-Tg-rg-IP2255-Ag-2;
GM-Tg-mg-IP2255-Ag-1/ GM-Tg-mg-IP2255-Ag-2; GM-Tg-cynog-IP2255-Ag-1/ GM-Tg-cynog-IP2255-Ag-2;
GM-Tg-felg-IP2255-Ag-1/ GM-Tg-felg-IP2255-Ag-2; GM-Tg-cang-IP2255-Ag-1/ GM-Tg-cang-IP2255-Ag-2;
GM-Tg-bovg-IP2255-Ag-1/ GM-Tg-bovg-IP2255-Ag-2; GM-Tg-equg-IP2255-Ag-1/ GM-Tg-equg-IP2255-Ag-2
Products Name USP19 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name USP19
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine USP19 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.